UPMC to lead $35 mln investment in medCPU
UPMC, a Pittsburgh-based health system, will take a majority interest in privately held medCPU Inc, a medical decision support company based in New York. In addition to the stock purchase, UPMC will lead an investment round of $35 million in new capital with participation from existing medCPU shareholder Merck Global Health Innovation Fund. UPMC will also become a medCPU customer.
29 February 2016•4 mins read
